In this video Thomas Wisniewski, MD, director of NYU Langone’s Alzheimer’s Disease Research Center, discusses recent advancements in Alzheimer's disease care.

Table of Contents Transforming Treatment Approaches From Lab Discovery to Clinical Impact Paper Summary In a nutshell A new ...

The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring ...

It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been ...

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

A vaccination to prevent horribly painful shingles may offer an extra benefit: New research suggests it might lower the risk ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but ...

The new test could help identify which patients are most likely to benefit from new Alzheimer’s drugs. A newly developed ...

Plasma eMTBR-tau243 shows a strong correlation with tau pathology and cognitive decline, offering a less invasive alternative to tau-PET imaging. Study: Plasma MTBR-tau243 biomarker identifies tau ...

The scientists concluded that while the two markers perform similarly, they yield complementary information, and sequential ...